최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기British journal of pharmacology : BJP, v.120 no.3, 1997년, pp.399 - 404
Kim, Young Il , Fluckiger, Laurence , Hoffman, Maurice , Lartaud‐Idjouadiene, Isabelle , Atkinson, Jeffrey , Maincent, Thilippe
The therapeutic use of nifedipine is limited by the rapidity of the onset of its action and its short biological half‐life. In order to produce a form devoid of these disadvantages we made nanoparticles of nifedipine from three different polymers, poly‐ɛ‐caprolactone (PCL)...
Al-Turk, W.A., Majeed, I.A., Murray, W.J., Newton, D.W., Othman, S.. Some factors affecting the photodecomposition of nifedipine. International journal of pharmaceutics, vol.41, no.3, 227-230.
Beck, P., Scherer, D., Kreuter, J.. Separation of drug-loaded nanoparticles from free drug by gel filtration. Journal of microencapsulation, vol.7, no.4, 491-496.
Bittar, N.. Usefulness of nifedipine for myocardial ischemia and the nifedipine gastrointestinal therapeutic system. The American journal of cardiology, vol.64, no.11, F31-F34.
Bodmeier, R., Chen, H., Tyle, P., Jarosz, P.. Spontaneous formation of drug-containing acrylic nanoparticles. Journal of microencapsulation, vol.8, no.2, 161-170.
Chillon, Jean‐Marc, Capdeville‐Atkinson, Christine, Lartaud, Isabelle, Guillou, Joel, Mertès, Paul‐Michel, Atkinson, Jeffrey. Chronic antihypertensive treatment with captopril plus hydrochlorothiazide improves aortic distensibility in the spontaneously hypertensive rat. British journal of pharmacology : BJP, vol.107, no.3, 710-714.
Fessi, H., Puisieux, F., Devissaguet, J.P., Ammoury, N., Benita, S.. Nanocapsule formation by interfacial polymer deposition following solvent displacement. International journal of pharmaceutics, vol.55, no.1, R1-R4.
Proc. Int. Sym. Control. Rel. Bioac. Mat. Gilley R.M. 123 15 1988 Development of secretory and systemic immunity following oral administration of microencapsulated antigens
Grangier, J.L., Puygrenier, M., Gautier, J.C., Couvreur, P.. Nanoparticles as carriers for growth hormone releasing factor. Journal of controlled release : official journal of the Controlled Release Society, vol.15, no.1, 3-13.
Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Deprez-Decampeneere, D., Speiser, P.. Pharmacokinetics and distribution of a biodegradable drug-carrier. International journal of pharmaceutics, vol.15, no.3, 335-345.
Hubert, Brigitte, Atkinson, Jeffrey, Guerret, Madeleine, Hoffman, Maurice, Devissaguet, Jean Philippe, Maincent, Philippe. The Preparation and Acute Antihypertensive Effects of a Nanocapsular Form of Darodipine, a Dihydropyridine Calcium Entry Blocker. Pharmaceutical research, vol.8, no.6, 734-738.
Kreuter, J., Muller, U., Munz, K.. Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles. International journal of pharmaceutics, vol.55, no.1, 39-45.
Lehr, C.-M., Bouwstra, J.A., Tukker, J.J., Junginger, H.E.. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat-A comparative study with copolymers and blends based on poly(acrylic acid). Journal of controlled release : official journal of the Controlled Release Society, vol.13, no.1, 51-62.
Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms Lehmann K.O.R. 153 1989
Proc. Int. Sym. Control. Rel. Bioact. Mat. Maincent P. 33 21 1994 Interest of colloidal carriers as vectors of antihypertensive dihydropyridine calcium‐entry blockers to decrease blood pressure in hypertensive rats
Makki, Touria, Talom, Rabelais Tatchum, Niederhoffer, Nathalie, Amin, Fatiha, Tankosic, Pierre, Mertès, Paul‐Michel, Atkinson, Jeffrey. Increased arterial distensibility induced by the angiotensin‐converting enzyme inhibitor, lisinopril, in normotensive rats. British journal of pharmacology : BJP, vol.111, no.2, 555-560.
Miyazaki, K., Kohri, N., Arita, T., Shimono, H., Katoh, K., Nomura, A., Yasuda, H.. High-performance liquid chromatographic determination of nifedipine in plasma. Journal of chromatography. biomedical applications, vol.310, 219-222.
J. Hypertension Myers M.G. S73 12 8 1994 Dihydropyridine calcium antagonists and the trough: peak ratio: focus on adverse effects
Eur. J. Hosp. Pharm. Ogawa Y. 120 2 1992 Monthly microcapsule‐depot form of LHRH agonist, leuprorelin acetate (Enantone® Depot): Formulation and pharmacokinetics in animals
Arzneim-Forsch/Drug Res. Pabst G. 256 36 1986 Pharmakinetics and bioavailability of three different galenic nifedipine preparations
Raemsch, K D, Sommer, J. Pharmacokinetics and metabolism of nifedipine.. Hypertension, vol.5, no.4,
Sorkin, E.M., Clissold, S.P., Brogden, R.N.. Nifedipine A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy, in Ischaemic Heart Disease, Hypertension and Related Cardiovascular Disorders :. Drugs, vol.30, no.3, 182-274.
J. Anat. Tilney N.L. 369 109 1971 Patterns of lymphatic drainage in the adult laboratory rat
J. Hypertension Van Zwieten P.A. S117 12 8 1994 Trough: peak ratio: measurement limitation and relevance to treatment of hypertension. Closing remarks
Washington, C.. Evaluation of non-sink dialysis methods for the measurement of drug release from colloids: effects of drug partition. International journal of pharmaceutics, vol.56, no.1, 71-74.
Washington, C.. Drug release from microdisperse systems: a critical review. International journal of pharmaceutics, vol.58, no.1, 1-12.
J. Hypertension Zanchetti A. S97 12 8 1994 Trough: peak ratio of blood pressure response to dihydropyridine calcium antagnoists
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.